Existing bitter medicines for fighting 2019‐nCoV‐associated infectious diseases
Open Access
- 13 April 2020
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 34 (5), 6008-6016
- https://doi.org/10.1096/fj.202000502
Abstract
The sudden outbreak of COVID-19 has led to more than seven thousand deaths. Unfortunately, there are no specific drugs available to cure this disease. Type 2 taste receptors (TAS2Rs) may play an important role in host defense mechanisms. Based on the idea of host-directed therapy (HDT), we performed a negative co-expression analysis using big data of 60 000 Affymetrix expression arrays and 5000 TCGA data sets to determine the functions of TAS2R10, which can be activated by numerous bitter substances. Excitingly, we found that the main functions of TAS2R10 involved controlling infectious diseases caused by bacteria, viruses, and parasites, suggesting that TAS2R10 is a key trigger of host defense pathways. To quickly guide the clinical treatment of 2019-nCoV, we searched currently available drugs that are agonists of TAS2Rs. We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV. We suggest that a cocktail-like recipe of existing bitter drugs may help doctors to fight this catastrophic disease and that the general public may drink or eat bitter substances, such as coffee, tea, or bitter vegetables, to reduce the risk of infection.Keywords
Funding Information
- China Postdoctoral Science Foundation (2019M651615, 2018229)
This publication has 60 references indexed in Scilit:
- Systemic diphenidol reduces neuropathic allodynia and TNF-alpha overexpression in rats after chronic constriction injuryNeuroscience Letters, 2013
- Bitter taste receptor research comes of age: From characterization to modulation of TAS2RsSeminars in Cell & Developmental Biology, 2013
- Amino Acids and Peptides Activate at Least Five Members of the Human Bitter Taste Receptor FamilyJournal of Agricultural and Food Chemistry, 2012
- T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infectionJCI Insight, 2012
- Extraoral bitter taste receptors as mediators of off‐target drug effectsThe FASEB Journal, 2012
- The Molecular Receptive Ranges of Human TAS2R Bitter Taste ReceptorsChemical Senses, 2009
- Broad Tuning of the Human Bitter Taste Receptor hTAS2R46 to Various Sesquiterpene Lactones, Clerodane and Labdane Diterpenoids, Strychnine, and DenatoniumJournal of Agricultural and Food Chemistry, 2007
- Elucidation of mammalian bitter tastePublished by Springer Science and Business Media LLC ,2005
- A Comparative Review of the Options for Treatment of Erectile DysfunctionDrugs, 2005
- Treatment of UrticariaAmerican Journal of Clinical Dermatology, 2001